Precision Optics Corporation Reports Revenue Decline Amid Market Challenges

Precision Optics Corporation, Inc. ( (POCI) ) has released its Q3 earnings. Here is a breakdown of the information Precision Optics Corporation, Inc. presented to its investors.

Precision Optics Corporation, Inc. is a Massachusetts-based company specializing in the development and manufacturing of advanced optical instruments, primarily serving the medical device industry with unique capabilities in 3D endoscopes and micro-precision lenses.

In its latest earnings report for the quarter ended March 31, 2025, Precision Optics Corporation reported a decline in revenues and gross profit compared to the previous year. The company faced challenges in its engineering design services and finished products segments, although it saw growth in its optical components division.

Key financial metrics revealed a 20.2% decrease in quarterly revenues to $4.19 million, with a significant drop in gross margin to 10% from 35.5% in the previous year. The company also reported a net loss of $2.1 million for the quarter, attributed to lower demand and increased operational costs.

Despite the current financial setbacks, Precision Optics Corporation continues to invest in research and development, focusing on new technologies and products for the evolving single-use medical device market. The company aims to leverage its expertise in micro-precision optics to capture new opportunities.

Looking ahead, the management remains focused on expanding its customer pipeline and enhancing its product offerings to drive future growth. The company anticipates that its strategic initiatives and investments in innovation will position it well for long-term success in the competitive medical device industry.